ARTICLE | Clinical News
NOMAC/E2: Completed Phase III enrollment
May 28, 2007 7:00 AM UTC
AKZ's Organon BioSciences N.V. unit completed enrollment of 2,320 patients in the open-label, active-controlled, international Phase III 292002 trial to compare oral NOMAC/E2 vs. separate 2.5 mg of N...